800 Corporate Drive, Suite 301, Stafford, VA 22554, USA



Headquartered in Washington, DC, BioInformant is the world’s first and only market research firm to specialize in the stem cell industry. When it was incorporated in 2006, BioInformant’s Founder and President, Cade Hildreth, was completing a M.S. in Biochemistry and Molecular Biology with a Specialization in Bioinformatics, the study of analyzing large quantities of biological data.

Pulling together a talented team of bioinformatics experts from around Washington, DC, Cade launched BioInformant with the belief that tracking the stem cell industry had to be an easier task than analyzing billions of base pairs of DNA.

2006 was an exciting time to be entering the industry, because Shinya Yamanaka had recently discovered induced pluripotent stem cells (iPS cells), and other stem cell types like mesenchymal stem cells (MSCs), were starting to show therapeutic promise. However, the enormous potential of stem cells had not yet been discovered.

Headquartered in Washington, DC, to be near NIH and FDA headquarters, BioInformant became distinctively suited to tracking the marketplace, as our database of historical information on which to base market predictions grew more and more robust.

Who is BioInformant Today?
Today, BioInformant continues to serve all-star clients, but we also serve the public. Cade regularly speaks as a media expert on stem cell market trends, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine.

Posted in Services

Reviews are disabled, but trackbacks and pingbacks are open.

Related Listings